Pages that link to "Q34731407"
Jump to navigation
Jump to search
The following pages link to Mood disorders: regulation by metabotropic glutamate receptors (Q34731407):
Displaying 50 items.
- Sigma receptors: potential targets for a new class of antidepressant drug (Q24567770) (← links)
- Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation (Q26770754) (← links)
- Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window (Q26775243) (← links)
- Zinc in the Glutamatergic Theory of Depression (Q26786214) (← links)
- Review of pharmacological treatment in mood disorders and future directions for drug development. (Q26853509) (← links)
- Homer1/mGluR5 activity moderates vulnerability to chronic social stress (Q27311111) (← links)
- Current investigational drugs for major depression (Q28244223) (← links)
- Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies (Q28751388) (← links)
- Metabotropic glutamate receptors: from the workbench to the bedside (Q30448778) (← links)
- Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas (Q33591900) (← links)
- Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants (Q33604879) (← links)
- From synapse to nucleus: novel targets for treating depression (Q33653177) (← links)
- Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression (Q33678656) (← links)
- Intracranial self-stimulation to evaluate abuse potential of drugs. (Q33845750) (← links)
- miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment (Q33864410) (← links)
- Chronic corticosterone administration down-regulates metabotropic glutamate receptor 5 protein expression in the rat hippocampus (Q34054096) (← links)
- On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039. (Q34130874) (← links)
- Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease (Q34269340) (← links)
- Mutagenesis and molecular modeling of the orthosteric binding site of the mGlu2 receptor determining interactions of the group II receptor antagonist (3)H-HYDIA. (Q34978304) (← links)
- Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder (Q35043972) (← links)
- Altered ADAR 2 equilibrium and 5HT2CR editing in the prefrontal cortex of ADAR 2 transgenic mice (Q35148503) (← links)
- Signaling pathways underlying the rapid antidepressant actions of ketamine (Q35375293) (← links)
- A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists (Q36118958) (← links)
- Nicotine exposure during adolescence alters the rules for prefrontal cortical synaptic plasticity during adulthood (Q36135851) (← links)
- Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function (Q36526498) (← links)
- Nicotine exposure during adolescence leads to short- and long-term changes in spike timing-dependent plasticity in rat prefrontal cortex (Q36554456) (← links)
- Glutamate transporters in brain ischemia: to modulate or not? (Q36745208) (← links)
- Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice (Q36788384) (← links)
- Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications (Q37121338) (← links)
- The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders (Q37172873) (← links)
- Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models (Q37206280) (← links)
- Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse (Q37412503) (← links)
- Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2. (Q37423436) (← links)
- Metabotropic glutamate receptors: physiology, pharmacology, and disease (Q37670222) (← links)
- New approaches to the pharmacological management of major depressive disorder (Q37709574) (← links)
- Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists (Q37775612) (← links)
- Does conventional anti-bipolar and antidepressant drug therapy reduce NMDA-mediated neuronal excitation by downregulating astrocytic GluK2 function? (Q37861320) (← links)
- Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeutics (Q38031832) (← links)
- mGluR2 positive allosteric modulators: a patent review (2009 - present). (Q38085707) (← links)
- Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder (Q38543238) (← links)
- Upregulation of prefrontal metabotropic glutamate receptor 5 mediates neuropathic pain and negative mood symptoms after spinal nerve injury in rats. (Q38603032) (← links)
- Tyrosine phosphorylation of glutamate receptors by non-receptor tyrosine kinases: roles in depression-like behavior (Q38678531) (← links)
- Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response (Q38823641) (← links)
- In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688. (Q38976686) (← links)
- Noncoding RNAs in Depression (Q39317369) (← links)
- Primate-specific Long Non-coding RNAs and MicroRNAs (Q39365422) (← links)
- Two grams of sarcosine in schizophrenia - is it too much? A potential role of glutamate-serotonin interaction. (Q41945244) (← links)
- A behavioral and molecular analysis of ketamine in zebrafish (Q42027177) (← links)
- Targeting glial physiology and glutamate cycling in the treatment of depression (Q42056797) (← links)
- Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate receptors in vivo (Q42689777) (← links)